|Articles|December 2, 2001
- Pharmaceutical Technology-12-02-2001
- Volume 25
- Issue 12
Bioterrorism Threat Shines Spotlight on Drug Manufacturing
Author(s)Jill Wechsler
Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.
Advertisement
Articles in this issue
about 24 years ago
E-Sourcing: Internet Facilitates Flexible Collaborationabout 24 years ago
International Employment Survey 2001about 24 years ago
Outsourcing Outlookabout 24 years ago
A Comprehensive Approach to Pharmaceutical Engineering TrainingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
